ylzzcom永利总站线路检测_ylzz总站线路检测

ylzzcom永利总站线路检测

En

En

中文简体

中文繁体

Integrated Development

As a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

  • Pharmaceutical Manufacturing

  • Vaccines

  • Medical Devices

  • Medical Diagnosis

  • Healthcare Services

  • Pharmaceutical Distribution and Retail

Steady Financial Growth

  • FY2022 Revenue

    43,952 million

    Increase of 12.66%

  • FY2022 Net Profit after deducting extraordinary gain or loss attributable to owners of the parent

    3,873 million

    Increase of 18.17%

  • FY2022 Net Cash Flow from operating activities

    4,218 million

    Increase of 7.1%

* Unit: RMB million
As of 31 December 2022

Open R&D Ecology

  • In-house R&D
  • Co-Development
  • In-depth Incubation
  • License-in
  • Pharmaceutical Manufacturing

    Pharmaceutical Manufacturing

    Pharmaceutical manufacturing is the core business of Fosun Pharma, including three major segments: innovator drugs, mature products and manufacturing, and vaccines.

    • Oncology and Immunomodulation
    • Metabolism and Digestive System
    • Central Nervous System
    • Anti-infection
    • Cardiovascular System
    • APIs and Intermediates
  • Vaccines

    Vaccines

    The Vaccine Division has established an independent R&D system centered on two major technical platforms of bacterial vaccines and viral vaccines, and further broadened the vaccine pipeline through cooperative development to enhance the vaccine industrialization capability.

    • COVID-19
    • mRNA COVID-19 Vaccine
  • Medical Devices

    Medical Devices

    As one of the important segments of Fosun Pharma, Fosun Med-tech integrated several subsidiaries at home and abroad and has initially formed three major business divisions with medical aesthetics, Respiratory Health and professional medical care

    • Medical Aesthetics
    • Respiratory Health
    • Professional Medical Technology and Devices
  • Medical Diagnosis

    Medical Diagnosis

    Founded in 1989, Fosun Diagnosis adheres to the mission of "Integrating innovative diagnostic technologies and protecting global life and health", promotes the development of innovative technologies and products, focuses on in vitro diagnosis industry, and is committed to becoming the world's leading technology innovator of integrated medical diagnosis solutions.

    • Biochemical Diagnosis
    • Immune Diagnosis
    • Molecular Diagnosis
    • Microbiological Diagnosis
    • Chronic-care Management
    • Pathological Diagnosis
  • Healthcare Services

    Healthcare Services

    Taking ‘‘making families healthier and life better’’ as the mission, Fosun Health gives full play to its core industrial advantages in the fields of medical care, medicine, insurance, health consumption, digital and intelligent technology, etc. Fosun Health is committed to building a medical-grade, full-scenario and one-stop health ecosystem, and becoming a ‘‘leader of active family health management’’.

    • Special Disease Healthcare
    • Consumer & Healthcare Services
    • Pharmaceutical
    • E-Commerce Insurance
    • Healthcare Services
  • Pharmaceutical Distribution and Retail

    Pharmaceutical Distribution and Retail

    In 2003, Fosun Pharma and China National Pharmaceutical Group Corporation jointly established Sinopharm Group.
    Sinopharm Group is a distributor of pharmaceuticals and healthcare products and a leading supply chain service provider in China.

【网站地图】【sitemap】
友情链接:九州ku酷游  新葡的京集团3512vip  J9.COM  vwin德赢AC米兰合作  888集团6008登录入口  8455线路检测中心  77779193永利  大宝娱乐  公海彩船  j9九游会  百乐博  J9直营集团